The 20 Best Virilizing Ovarian Tumor Doctors Near Me in New Jersey, US

Nana Tchabo, MD, FACOG Dr. Nana Tchabo is dual board certified in gynecology-oncology and obstetrics and gynecology, with fellowship training in minimally invasive gynecologic surgery and robotic procedures. A native of Baltimore, MD, Dr. Tchabo is a gynecologic oncologist at Atlantic Health System’s Morristown and Overlook Medical Centers Women’s Cancer Center, part of the Atlantic Medical Group. After graduating from Brown University in 1996 with a bachelor’s degree in neuroscience and a minor in women’s health, Dr. Tchabo attended Brown University School of Medicine for her medical degree, where she was cited for academic excellence. Dr. Tchabo completed her residency in obstetrics and gynecology at Georgetown University in 2004 and pursued additional research training at the National Cancer Institute of the National Institutes of Health in Bethesda, MD, and gynecologic oncology fellowship training at Roswell Park Cancer Institute in Buffalo, NY. Committed to cancer prevention and survivorship, Dr. Tchabo is a principal investigator on many of the gynecologic cancer clinical research trials available at the Carol G. Simon Cancer Center. She also serves as associate residency director for Gynecology at Overlook Medical Center. Dr. Tchabo is an assistant clinical professor at the Sidney Kimmel Medical College of Thomas Jefferson University and is a former assistant clinical professor at Mount Sinai School of Medicine’s department of Obstetrics, Gynecology and Reproductive Science. Dr. Tchabo is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Endometrial Cancer, Ovarian Carcinosarcoma, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy.

Jason Knight is a Gynecologic Oncologist and an Oncologist in Morristown, New Jersey. Dr. Knight is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Oophorectomy, and Hysterectomy. Dr. Knight is currently accepting new patients.

Since 1999, Dr. Daniel Tobias has been a gynecologic oncologist at Atlantic Health System’s Women’s Cancer Center, diagnosing and treating conditions of the female reproductive system. He is dual board-certified in obstetrics and gynecology and gynecologic oncology, and he is part of Atlantic Medical Group with privileges at both Morristown and Overlook medical centers. He is currently the director of gynecologic oncology for Atlantic Health System.Dr. Tobias attended the University of Missouri-Kansas City School of Medicine for an integrated six-year combined bachelors of arts and medical degree program. He performed his residency at Albert Einstein College of Medicine’s Montefiore Medical Center and his fellowship in gynecologic oncology at Mount Sinai School of Medicine in New York. During his fellowship, Dr. Tobias served as principal investigator of a study initiated by the New York Gynecologic Oncology Group. Keenly interested in research, Dr. Tobias continues to bring clinical trials and research to his patients.As part of an integrated care team, Dr. Tobias treats gynecologic malignancies using a combination of modalities and advanced technologies to spare healthy tissue. His medical career includes many honors, awards, presentations and authored works.Dr. Tobias is affiliated with and involved in several professional societies including the Society of Gynecology Oncologists and the American College of Obstetricians and Gynecologists. He has extensive experience with radical surgery, intraperitoneal chemotherapy and laparoscopic surgery. Dr. Tobias has performed robotic surgery since 2005, helped develop a comprehensive gynecologic oncology robotics program, and trains other physicians to perform robotics surgery. He also participates in resident education. Dr. Tobias is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Endometrial Cancer, Endometrial Stromal Sarcoma, Malignant Mixed Mullerian Tumor, Hysterectomy, and Oophorectomy.

Noah Lindenberg is a Hematologist and a Hematologist Oncology provider in Marlton, New Jersey. Dr. Lindenberg is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Childhood Iron Deficiency Anemia, Iron Deficiency Anemia, Familial Colorectal Cancer, and Lung Cancer. Dr. Lindenberg is currently accepting new patients.

May Matkiwsky is a Hematologist and an Oncologist in Sparta, New Jersey. Dr. Matkiwsky is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Paget Disease of the Breast, Colorectal Cancer, Familial Colorectal Cancer, Drug-Induced Thrombocytopenia, and Bone Marrow Aspiration. Dr. Matkiwsky is currently accepting new patients.

Jason Konner is an Oncologist in Middletown, New Jersey. Dr. Konner is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Ovarian Carcinosarcoma, and Salpingo-Oophorectomy.

Thad Denehy is an Oncologist in West Orange, New Jersey. Dr. Denehy is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Vulvar Cancer, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Hysterectomy, and Oophorectomy. Dr. Denehy is currently accepting new patients.

Donna Mcnamara is an Oncologist in Hackensack, New Jersey. Dr. Mcnamara is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Paget Disease of the Breast, Inflammatory Breast Cancer, Breast Cancer, and Angiosarcoma.

Karim Elsahwi is a Gynecologic Oncologist and an Oncologist in Neptune, New Jersey. Dr. Elsahwi is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Ovarian Cancer, Hysterectomy, and Oophorectomy.

Deena Graham is an Oncologist in Hackensack, New Jersey. Dr. Graham is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Gastrostomy.

David Sokol is a Hematologist and an Oncologist in Plainsboro, New Jersey. Dr. Sokol is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Non-Hodgkin Lymphoma, Ovarian Carcinosarcoma, Virilizing Ovarian Tumor, Testicular Yolk Sac Tumor, and Bone Marrow Aspiration. Dr. Sokol is currently accepting new patients.

Dr. Sonyo Shin is an esteemed attending hematologist/oncologist at Advanced Care Oncology and Hematology Associates (ACOHA), a distinguished part of Atlantic Medical Group (AMG). With over 20 years of dedicated experience in the field, she is deeply committed to delivering patient-centered care in both hematology and oncology.Dr. Shin is board-certified in internal medicine, oncology, and hematology by the American Board of Internal Medicine. Her extensive expertise encompasses the treatment of a wide range of malignancies, including lymphoma, lung cancer, and chronic leukemia. She has been instrumental in developing and leading multidisciplinary breast cancer clinics, ensuring a comprehensive approach to patient care.In addition to her clinical practice, Dr. Shin is actively involved in clinical trials, contributing to the advancement of cancer research. She is also passionate about education, mentoring medical residents and students to foster the next generation of healthcare professionals. Her commitment to excellence in patient care and education underscores her role as a leader in the field of hematology and oncology. Dr. Shin is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Paget Disease of the Breast, Familial Colorectal Cancer, Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.

Justin Chura is a Pathologist in Swedesboro, New Jersey. Dr. Chura is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Sertoli-Leydig Cell Tumor, Ovarian Carcinosarcoma, Malignant Mixed Mullerian Tumor, and Testicular Yolk Sac Tumor.

David Warshal is an Oncologist in Camden, New Jersey. Dr. Warshal has been practicing medicine for over 40 years and is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Ovarian Cancer, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Hysterectomy, and Lymphadenectomy.

Christina Chu is a Hematologist Oncology specialist and an Oncologist in Camden, New Jersey. Dr. Chu has been practicing medicine for over 31 years and is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Ovarian Cancer, Endometrial Cancer, Sertoli-Leydig Cell Tumor, Hysterectomy, and Oophorectomy.

Meredith Duffy is an Oncologist and an Anesthesiologist in Camden, New Jersey. Dr. Duffy has been practicing medicine for over 26 years and is rated as a Distinguished provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Vulvar Cancer, Desmoplastic Small Round Cell Tumor, Endometrial Cancer, and Endometrial Stromal Sarcoma.

Dr. Michael Scola is a board-certified, fellowship-trained hematologist oncologist practicing at Atlantic Hematology Oncology located at Morristown Medical Center. For the past 20 years, Dr. Scola has maintained a broad-based clinical practice, with a focus on benign and malignant hematology. He is currently director of the new Atlantic Thrombosis Center, designed to investigate and manage patients with a variety of bleeding and clotting disorders. Dr. Scola is a skilled and compassionate physician. His postdoctoral training includes a fellowship in hematology oncology from Boston University Medical Center, where he received the Outstanding Fellow award and the Chiefs’ Hematology Award for clinical excellence. He received his medical degree from Baylor College of Medicine in Houston, TX. A teacher and mentor, Dr. Scola served many years as course director of pathophysiology at Northeastern University, Boston, and is actively involved in instructing residents at Morristown Medical Center. He is also involved in clinical research; has worked within the industry as a consultant, lecturer and advisor; and has authored articles and book chapters. Dr. Scola’s education includes a year spent abroad in Florence, Italy, and an intensive post-training program in clinical research at the Harvard School of Public Health. He serves on the boards of the Cancer Hope Network, and the Cancer Support Community of Central New Jersey. Dr. Scola is a member of the American Society of Hematology, American Society of Clinical Oncology and the International Society of Thrombosis and Hemostasis. Dr. Scola is rated as an Advanced provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Chronic Myelogenous Leukemia (CML), Philadelphia-Negative Chronic Myeloid Leukemia, Non-Hodgkin Lymphoma, Anemia, and Bone Marrow Aspiration.

Maithili Rao, MD, is a senior health care entrepreneur board-certified in medical oncology and hematology by the American Board of Internal Medicine. She is affiliated with Advanced Care Oncology and Hematology Associates (ACOHA), part of Atlantic Medical Group (AMG). Her professional career includes building a worldclass oncology practice across six counties with 30 practitioners, serving as a medical executive board member at Overlook Hospital, and working as the enterprise medical director of Practice Growth and Integration at Atlantic Medical Group. Dr. Rao has championed an integrated approach to treating cancer and blood disorders, focusing on personalizing patient care, quality, and communication.At each oncology treatment site, Dr. Rao has successfully incorporated palliative care, genetic counseling, dietitians, navigators, social workers, onsite lab and pharmacy services, access to clinical trials, an infusion suite for chemotherapy and immunotherapy, and advanced molecular testing. These integrations enable her to deliver high-quality clinical care and innovative treatment protocols with a unique, holistic, patient-centered approach. She treats all forms of blood disease and cancer, with a special focus on breast cancer.Dr. Rao currently serves as the enterprise medical director of oncology and other specialties for Atlantic Health System (AHS), a multi-award-winning, seven-hospital, nonprofit, integrated health care network in northern New Jersey. AHS has over 400 sites of care, 300 physician practices, and 17,000 team members. Dr. Rao provides clinical and strategic direction for cancer care and has successfully transformed cancer care in New Jersey from a community-focused initiative to a leading oncology center that rivals prestigious competitors in New York City.Dr. Rao has been recognized by the American Cancer Society as a Medical Honoree and has been voted by her peers as New Jersey Monthly’s Top Doctor for over 13 years, among other accolades. Dr. Rao is a member of the American Society of Clinical Oncology and the American Society of Hematology, and is a participating provider of the Atlantic Accountable Care Organization. Dr. Rao is rated as an Advanced provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Myelodysplastic Syndrome (MDS), Thrombocytopenia, and Bone Marrow Aspiration.

Robin Wilson is an Oncologist and a General Surgeon in Sewell, New Jersey. Dr. Wilson is rated as an Advanced provider by MediFind in the treatment of Virilizing Ovarian Tumor. Her top areas of expertise are Endometrial Cancer, Malignant Mixed Mullerian Tumor, Endometrial Stromal Sarcoma, Sertoli-Leydig Cell Tumor, and Hernia Surgery. Dr. Wilson is currently accepting new patients.

Dr. Charles Farber is a board-certified, fellowship-trained oncologist at Atlantic Hematology Oncology located at Morristown Medical Center’s Carol G. Simon Cancer Center. He maintains a broad-based practice, yet focuses on benign and malignant hematology. Dr. Farber also serves as medical director of Oncology Research Network Development for Atlantic Health System. In this role, he works with the system’s Breakthrough Oncology Accelerator partners, Translational Genomics Research Institute (TGen) and OriginCV, to expand cancer research at Morristown Medical Center and throughout Atlantic Health System. This partnership ensures that patients have access to the newest and most exciting drugs and technologies through clinical trials. In addition to receiving multiple Patient’s Choice Awards, Dr. Farber has been recognized as a Top Doctor in the New York Metro Area, and listed in Inside Jersey magazine’s Top Doctors, and Consumers Research Council’s Guide to America’s Top Oncologists. He is regarded by colleagues and patients as a knowledgeable, compassionate and devoted physician and has been providing expert care to the Morristown community for more than 20 years. Dr. Farber attended New York University School of Medicine for his medical degree and performed his residency and fellowship at Weill Cornell Medical Center. He also earned a master’s degree and PhD from New York University’s Graduate School of Arts and Sciences. Dr. Farber chairs Morristown Medical Center’s cancer subcommittee for adolescents and young adults and serves as secretary and treasurer of the Oncology Society of New Jersey. He was former chief of the division of Hematology/Oncology at Morristown Medical Center from 2007 to 2011. Dr. Farber serves as a clinical assistant professor at Rutgers and at the Cancer Institute of New Jersey. His research has been published in the Journal of the American Nutraceutical Association, the New England Journal of Medicine and the National Cancer Institute’s Clinical Trial Directory. Dr. Farber is rated as an Advanced provider by MediFind in the treatment of Virilizing Ovarian Tumor. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Non-Hodgkin Lymphoma, Follicular Lymphoma, and Bone Marrow Aspiration.